Proquazone

CAS No. 22760-18-5

Proquazone( Arthrex | Biarison | Proquazona | Proquazonum | Proquazone )

Catalog No. M24037 CAS No. 22760-18-5

Proquazone is a nonsteroidal anti-inflammatory agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 212 In Stock
5MG 255 In Stock
10MG 332 In Stock
25MG 560 In Stock
50MG 783 In Stock
100MG 1079 In Stock
200MG Get Quote In Stock
500MG 2167 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Proquazone
  • Note
    Research use only, not for human use.
  • Brief Description
    Proquazone is a nonsteroidal anti-inflammatory agent.
  • Description
    Proquazone is a nonsteroidal anti-inflammatory agent.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Arthrex | Biarison | Proquazona | Proquazonum | Proquazone
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    22760-18-5
  • Formula Weight
    278.36
  • Molecular Formula
    C18H18N2O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:Soluble
  • SMILES
    O=C1N(C(C)C)C2=C(C=CC(C)=C2)C(C3=CC=CC=C3)=N1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.M?k?r?inen L, Ylikorkala O. Menstrual blood loss in dysmenorrhoea: effects of proquazone and indomethacin. Br J Obstet Gynaecol. 1983 Jun;90(6):570-2.
molnova catalog
related products
  • JKE-1674

    JKE-1674 is an inhibitor of glutathione peroxidase 4 (GPX4). JKE-1674 is an active metabolite of the GPX4 inhibitor ML-210.

  • 4-O-Methylbutein

    4-O-Methylbutein (2',3,4'-trihydroxy-4-methoxychalcone) may have anti-inflammation activity, it is a potent heme oxygenase-1 (HO-1) inducer, the upregulation of HO-1 has proven to be a useful tool for fighting inflammation.

  • Ipivivint

    Ipivivint (Compound 38) is an orally active and potent CDC-like kinase (CLK) inhibitor with EC50s of 1 nM, 7 nM for CLK2 and CLK3, respectively. Ipivivint inhibits Wnt pathway (EC50=13 nM).